Keytruda alone generated $29.5 billion in 2024, making its 2028 loss of exclusivity (LOE) the largest single revenue-erosion event in the history of the pharmaceutical industry
This issue came to the fore in early 2024 when the UK MHRA issued a National Patient Safety Alert triggered by global supply issues for certain GLP-1 drugs, advising healthcare professionals to conserve existing stock for patients with Type 2 diabetes.6,7 The implementation of such measures ensures that the critical priority of patient needs continues to be met, while also avoiding patients seeking what the WHO describes as falsified or substandard versions of these medicines through unregulated outlets on the internet.8 Looking to the future, demand for GLP-1 drugs is expected to remain high as healthcare systems look to manage obesity and diabetes among an ageing population
Where to Find GLP-1 Treatment in Fort Myers If youre looking for Fort Myers GLP-1 treatment options, Myerlee Pharmacy provides expert guidance and personalized care
Covers BtMG classification, AMG regulatory implications, required documentation, VAT rates, duty calculations, and step-by-step customs clearance procedures for laboratory researchers in Germany